GlassScriptPhysician profile
Neil K Goldstein
NPI 1235165226
$56,285.72
in general payments reported to CMS, 2019-2025
31 companies · $9,371 in 2025
The $9,371 reported for 2025 was more than what 89% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $2,496 · 2021: $4,107 · 2022: $4,167 · 2023: $4,034 · 2024: $9,935 · 2025: $9,371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $15K · Food and Beverage: $6,204 · Travel and Lodging: $2,136.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $15,000.00 |
| Food and Beverage | $6,204.36 |
| Travel and Lodging | $2,135.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $28,440.95 | 2019-2024 | Varithena Administration Pack, Ranger |
| Angiodynamics, INC. | $17,998.63 | 2020-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Medtronic, INC. | $1,458.04 | 2021-2023 | Ellipsys Vascular Access System |
| Mozarc Medical US LLC | $1,421.01 | 2023 | Argyle |
| Tactile Systems Technology INC | $1,298.05 | 2019-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Janssen Pharmaceuticals, INC | $716.48 | 2019-2024 | Xarelto |
| Koya Medical, INC. | $617.52 | 2024-2025 | Dayspring, Koya Medical, Dayspring |
| Organogenesis INC. | $565.53 | 2021-2024 | Puraply |
| Terumo Medical Corporation | $402.33 | 2020 | |
| Abbott Laboratories | $342.12 | 2019-2024 | Perclose Prostyle |
| Philips North America LLC | $313.79 | 2019-2025 | IV Other, (Br5) Peripheral Ivus |
| Becton, Dickinson and Company | $267.85 | 2025 | Lutonix Drug Coated Balloon, Venclose Maven Catheter |
| Bard Peripheral Vascular, INC. | $261.24 | 2021-2025 | Fluency Endovascular Stent Graft, Venovo |
| Siemens Medical Solutions USA, INC. | $246.66 | 2025 | Artis Icono Floor, Acuson Maple Diagnostic Ultrasound System, Embozene |
| Cardiovascular Systems INC. | $199.65 | 2020-2023 | Diamondback Peripheral |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reflow Medical INC | $179.78 | 2025 | |
| Sirtex Medical INC | $179.06 | 2024 | Sir-Spheres Microspheres |
| Biotronik INC. | $174.41 | 2022-2025 | Pulsar-18 T3 |
| Argon Medical Devices, INC. | $159.70 | 2019 | |
| Merit Medical Systems INC | $150.22 | 2020-2025 | Wrapsody Stent Graft |
| Cordis US Corp. | $150.00 | 2022 | |
| Smith+Nephew, INC. | $149.37 | 2020 | |
| Inari Medical, INC. | $137.82 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic Vascular, INC. | $124.81 | 2019 | |
| Amgen INC. | $97.48 | 2024-2025 | Repatha, Repatha |
| Cook Medical LLC | $81.43 | 2025 | Torcon Nb |
| Biowound Solutions, INC. | $46.09 | 2025 | Bio-Connekt |
| Cardiva Medical, INC. | $45.51 | 2021-2025 | Cardiva Vascade 6/7f Vcs |
| Avinger INC. | $24.86 | 2021 | |
| Nevro Corp. | $22.92 | 2023 | Senza |
| Veryan Medical Incorporated | $12.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neil Goldstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.